Caffeine Citrate · CAFFEINE CITRATE 20 mg/mL · Solution · Oral · Exela Pharma Sciences, LLC
NDC 51754-0501-02 · 5 VIAL in 1 CARTON / 3 mL in 1 VIAL · ANDA · View full market →
6 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Exela Pharma Sciences, LLC., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Armas Pharmaceuticals Inc. | CAFFEINE CITRATE 60 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Exela Pharma Sciences, LLC | CAFFEINE CITRATE 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | CAFFEINE CITRATE 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | CAFFEINE CITRATE 60 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CAFFEINE CITRATE 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | CAFFEINE CITRATE 20 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "caffeine citrate — NDC 51754-0501-02," retrieved September 3, 2026, https://drugdashboards.com/drug/51754050102.
Free to cite with attribution — see how the data is put together.